Trials / Completed
CompletedNCT00842855
Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France
Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 275 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe common treatment pathways, to collect health care utilization data and to assess symptom load as well as impact of symptoms on daily life in GERD patients who are partial-responders to PPI treatment.
Conditions
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2009-02-12
- Last updated
- 2011-02-07
Locations
44 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00842855. Inclusion in this directory is not an endorsement.